Related Experiment Videos
High-dose rate brachytherapy has a curative potential in patients with intraluminal squamous cell lung cancer
G Sutedja1, G Baris, N van Zandwijk
1Department of Pulmonary Medicine, Free University Hospital, Amsterdam, The Netherlands.
Respiration; International Review of Thoracic Diseases
|January 1, 1994
Abstract:
Two patients presented with intraluminal T1N0 squamous cell lung cancer. Poor lung function precluded surgical resection and/or external radiotherapy. They were treated up to 3 times with high-dose rate brachytherapy (10 Gy at 1 cm each session) with curative intent. Follow-up has been 54 and 25 months. Brachytherapy is an effective and well-tolerated bronchoscopic treatment alternative with a curative potential in patients with small T1N0 intraluminal lung cancer.